Global Glass Bioreactors Market Overview:
Glass bioreactors are the vessel suitable for optimal stirred tank mixing application and ensures an easy and efficient sterile process along with minimizing the lost batches. It is widely used in pharmaceutical, biotechnology, vaccine development, and biological research applications. Glass bioreactors are systems designed according to their specific demand for a process with standard components.
As per latest study released by AMA Research, the Global Glass Bioreactors market is expected to see growth rate of 7.0%Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Period | 2018-2023 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Increasing Use of Small-scale Single Use Glass Bioreactors In Vaccine Development
Market Growth Drivers:
Growing Chemical research and Development Activities and Demand for the Biotechnological Research For Production of Drugs
Challenges:
Limited Quantity and Small Batches Designed Glass Bioreactors
Restraints:
High Skills Required for Handling Glass Bioreactors
Opportunities:
Technological Advancement in the Glass Bioreactors and Surging Demand for Glass Bioreactors from Developing Countries Indulging in Lifesciences and Biotechnology
Competitive Landscape:
The global market is highly competitive and consists of a limited number of providers competing. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.
Some of the key players profiled in the report are Thermo Fisher Scientific Inc (United States), Pall Corporation (United States), Applikon Biotechnology (Netherlands), Sartorius AG (Germany), GEA (Germany), PBS Biotech Inc. (United States), Solida Biotech (Germany), Culture Biosciences (United States), Eppendorf AG (Germany), Kemwell Biopharma (India) and bbi-biotech GmbH (Germany). Considering Market by Components, the sub-segment i.e. Microbial Cultures will boost the Glass Bioreactors market. Considering Market by Size Litres, the sub-segment i.e. 5L-20L will boost the Glass Bioreactors market. Considering Market by Operation, the sub-segment i.e. Automated will boost the Glass Bioreactors market.
Latest Market Insights:
On 27th April 2021, Kemwell Biopharma, a biologics contract development and manufacturing service provider has recently augmented its existing infrastructure. As part of this expansion strategy, the company has installed Ambr 250, high throughput equipment with 12 fully automated mini bioreactors at a 250 ml scale to accelerate process development.
On 25th January 2021, Culture Biosciences Announces High-Throughput Mammalian Cell Culture Capability for Cloud-Based Bioreactors. Culture Biosciences announced its high-throughput mammalian cell-culture capabilities have been proven out using CHO (Chinese Hamster Ovar) cell cultures. According to the white paper, Culture Biosciences was able to grow the cell lines from a customer and show reproducibility alongside internally developed cultures, as well as the ability to scale down results from a customer's 1 L glass bioreactors.
What Can be Explored with the Glass Bioreactors Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Glass Bioreactors Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Glass Bioreactors
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Glass Bioreactors market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Glass Bioreactors market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Glass Bioreactors Manufacturers, Glass Bioreactors International Traders, Glass Bioreactors Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.